Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Bioorg Med Chem. 2019 Nov 11;28(1):115193. doi: 10.1016/j.bmc.2019.115193

Figure 6.

Figure 6.

DYRK1A binding correlates to DYRK-NFAT EC50 and β-cell replication, while MELK binding does not correlate to cytotoxicity. (A) Selected compounds (5, 15, 21, 28, and 42) for which DYRK-NFAT EC50 was linear with DYRK1A Kd (R2=0.98) plotted as DYRK-NFAT EC50 vs DYRk1A Kd. (B) The same compounds (5, 15, 21, 28, and 42) with R-Luc CC50 plotted versus MELK Kd (R2=0.05). (C) The same compounds (5, 15, 21, 28, and 42) with human β-cell replication ECmin plotted versus DYRK1A Kd (R2=0.99).